Appoints Mario Alberto Accardi As CEO
11/12/2025 12:44
Dec 11 (Reuters) - Centessa Pharmaceuticals PLC 260y.F: CENTESSA PHARMACEUTICALS PLC - APPOINTS MARIO ALBERTO ACCARDI AS CEO CENTESSA PHARMACEUTICALS PLC - SAURABH SAHA TO STEP DOWN AS CEO EFFECTIVE JANUARY 1, 2026 CENTESSA PHARMACEUTICALS PLC - ORX750 REGISTRATIONAL PROGRAM EXPECTED TO INITIATE IN Q1 2026 Source text: ID:nGNX3BtHFs Further company coverage: [260y.F] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Centessa Pharmaceuticals
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Acquisition Of Centessa By Lilly Approved By The High Court Of Justice Of England And Wales
Street View: Lilly's $7.8 billion Centessa buyout validates sleep‑drug market
Press Digest: New York Times business news - April 1